Maternal, fetal and neonatal outcomes among pregnant women receiving COVID-19 vaccination: The preg-co-vax study

Maternal, fetal and neonatal outcomes among pregnant women receiving COVID-19 vaccination: The preg-co-vax study

IntroductionAlthough the European Medicines Agency (EMA) encourage coronavirus disease 2019 (COVID-19) vaccination in pregnant women, the scientific evidence supporting the use of COVID-19 vaccines during pregnancy is still limited.AimWe aimed to investigate adverse events following immunization (AE...

Full description

Bibliographic Details
Main Authors:	Annamaria Mascolo, Gabriella di Mauro, Federica Fraenza, Mario Gaio, Alessia Zinzi, Ciro Pentella, Francesco Rossi, Annalisa Capuano, Liberata Sportiello
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2022-10-01
Series:	Frontiers in Immunology
Subjects:	pregnant women COVID-19 vaccines maternal exposure during pregnancy adverse events following immunization pharmacovigilance database
Online Access:	https://www.frontiersin.org/articles/10.3389/fimmu.2022.965171/full

Similar Items

Immune Checkpoint Inhibitors and Immune-Related Adverse Drug Reactions: Data From Italian Pharmacovigilance Database
by: Rosanna Ruggiero, et al.
Published: (2020-06-01)

Sex and gender differences and pharmacovigilance: a knot still to be untied
by: Liberata Sportiello, et al.
Published: (2024-04-01)

Which is the top player for the cardiovascular safety? ibrutinib vs. obinutuzumab in CLL
by: Annamaria Mascolo, et al.
Published: (2023-08-01)

Quinolones-Induced Musculoskeletal, Neurological, and Psychiatric ADRs: A Pharmacovigilance Study Based on Data From the Italian Spontaneous Reporting System
by: Cristina Scavone, et al.
Published: (2020-04-01)

Capillary leak syndrome following COVID-19 vaccination: Data from the European pharmacovigilance database Eudravigilance
by: Rosanna Ruggiero, et al.
Published: (2022-09-01)

Safety Monitoring of mRNA COVID-19 Vaccines in Children Aged 5 to 11 Years by Using EudraVigilance Pharmacovigilance Database: The CoVaxChild Study
by: Alessia Zinzi, et al.
Published: (2023-02-01)

Glucagon-like Peptide-1 Receptor Agonists and Suicidal Ideation: Analysis of Real-Word Data Collected in the European Pharmacovigilance Database
by: Rosanna Ruggiero, et al.
Published: (2024-01-01)

Real-World Safety Data of the Orphan Drug Onasemnogene Abeparvovec (Zolgensma<sup>®</sup>) for the SMA Rare Disease: A Pharmacovigilance Study Based on the EMA Adverse Event Reporting System
by: Rosanna Ruggiero, et al.
Published: (2024-03-01)

Do peripheral neuropathies differ among immune checkpoint inhibitors? Reports from the European post-marketing surveillance database in the past 10 years
by: Rosanna Ruggiero, et al.
Published: (2023-03-01)

The Reporting Frequency of Ketoacidosis Events with Dapagliflozin from the European Spontaneous Reporting System: The DAPA-KETO Study
by: Gabriella di Mauro, et al.
Published: (2022-02-01)

A Pharmacovigilance Study on the Safety of Axicabtagene Ciloleucel Based on Spontaneous Reports from the EudraVigilance Database
by: Concetta Rafaniello, et al.
Published: (2023-08-01)

Did the New Italian Law on Mandatory Vaccines Affect Adverse Event Following Immunization’s Reporting? A Pharmacovigilance Study in Southern Italy
by: Cristina Scavone, et al.
Published: (2018-09-01)

Sodium-glucose cotransporter–2 (SGLT2) inhibitors and the reporting of falls and fractures: an european pharmacovigilance analysis
by: Annamaria Mascolo, et al.
Published: (2023-11-01)

The Role of Renin-Angiotensin-Aldosterone System in the Heart and Lung: Focus on COVID-19
by: Annamaria Mascolo, et al.
Published: (2021-04-01)

Disease-Modifying Therapies (DMTs) in Pregnant and Lactating Women with Multiple Sclerosis: Analysis of Real-World Data from EudraVigilance Database
by: Liberata Sportiello, et al.
Published: (2023-11-01)

The safety of blinatumomab in pediatric patients with acute lymphoblastic leukemia: A systematic review and meta-analysis
by: Maria Maddalena Marrapodi, et al.
Published: (2022-07-01)

The Safety Profiles of Two First-Generation NTRK Inhibitors: Analysis of Individual Case Safety Reports from the FDA Adverse Event Reporting System (FAERS) Database
by: Valerio Liguori, et al.
Published: (2023-09-01)

Tisagenlecleucel in Children and Young Adults: Reverse Translational Research by Using Real-World Safety Data
by: Concetta Rafaniello, et al.
Published: (2020-09-01)

Decolonization of drug-resistant Enterobacteriaceae carriers: A scoping review of the literature
by: Annamaria Mascolo, et al.
Published: (2023-03-01)

European Safety Analysis of mRNA and Viral Vector COVID-19 Vaccines on Glucose Metabolism Events
by: Gabriella di Mauro, et al.
Published: (2022-05-01)

Cardiac Events Potentially Associated to Remdesivir: An Analysis from the European Spontaneous Adverse Event Reporting System
by: Concetta Rafaniello, et al.
Published: (2021-06-01)

Late relapse after CAR-T cell therapy for adult patients with hematologic malignancies: A definite evidence from systematic review and meta-analysis on individual data
by: Alessia Zinzi, et al.
Published: (2023-04-01)

Disease-modifying therapies and hematological disorders: a systematic review of case reports and case series
by: Cristina Scavone, et al.
Published: (2024-06-01)

Safety profile of sodium glucose co-transporter 2 (SGLT2) inhibitors: A brief summary
by: Annamaria Mascolo, et al.
Published: (2022-09-01)

Oro-Dental Pharmacovigilance in the Digital Age: Promoting Knowledge, Awareness, and Practice in Italy through a Smart Combined System—A Conference at the 30th National Congress of the Italian College of University Professors of Dental Disciplines
by: Gaetano La Mantia, et al.
Published: (2023-09-01)

Thromboembolic Events after COVID-19 Vaccination: An Italian Retrospective Real-World Safety Study
by: Francesca Futura Bernardi, et al.
Published: (2023-10-01)

Italian Emergency Department Visits and Hospitalizations for Outpatients’ Adverse Drug Events: 12-Year Active Pharmacovigilance Surveillance (The MEREAFaPS Study)
by: Niccolò Lombardi, et al.
Published: (2020-04-01)

Safety of Anticancer Agents Used in Children: A Focus on Their Off-Label Use Through Data From the Spontaneous Reporting System
by: Annamaria Mascolo, et al.
Published: (2020-05-01)

Disentangling a Thorny Issue: Myocarditis and Pericarditis Post COVID-19 and Following mRNA COVID-19 Vaccines
by: Concetta Rafaniello, et al.
Published: (2022-04-01)

The Safety Profile of General and Local Anaesthetic Agents: Data Collected during 20 Years of Spontaneous Reporting Activities in the Campania Region (Southern Italy)
by: Francesca Gargano, et al.
Published: (2021-12-01)

COVID-19 Vaccines and Atrial Fibrillation: Analysis of the Post-Marketing Pharmacovigilance European Database
by: Rosanna Ruggiero, et al.
Published: (2023-05-01)

Multisystem Inflammatory Syndrome in Children Following COVID-19 Vaccination: A Sex-Stratified Analysis of the VAERS Database Using Brighton Collaboration Criteria
by: Valerio Liguori, et al.
Published: (2023-08-01)

The Pharmacological Treatment of Chronic Pain: From Guidelines to Daily Clinical Practice
by: Gianmarco Marcianò, et al.
Published: (2023-04-01)

Pregnancy Recommendations Solely Based on Preclinical Evidence Should Be Integrated with Real-World Evidence: A Disproportionality Analysis of Certolizumab and Other TNF-Alpha Inhibitors Used in Pregnant Patients with Psoriasis
by: Mario Gaio, et al.
Published: (2024-07-01)

Pattern of statin use in southern italian primary care: can prescription databases be used for monitoring long-term adherence to the treatment?
by: Carmen Ferrajolo, et al.
Published: (2014-01-01)

Drug Utilization and Measurement of Medication Adherence: A Real World Study of Psoriasis in Italy
by: Sara Mucherino, et al.
Published: (2023-11-01)

Overview of Antiviral Drug Therapy for COVID-19: Where Do We Stand?
by: Renata Esposito, et al.
Published: (2022-11-01)

The Role of Social Influence in Anxiety and the Imposter Phenomenon
by: Christy Fraenza
Published: (2016-05-01)

Can Pharmacovigilance Data Represent a Potential Tool for Early Detection of the Antibiotic Resistance Phenomenon?
by: Cecilia Cagnotta, et al.
Published: (2024-10-01)

Hypernatremia During Intravenous Treatment With Fosfomycin: A Retrospective Medical Record Review Study and an Analysis of Spontaneous Reports in the EudraVigilance Database
by: Cristina Scavone, et al.
Published: (2022-03-01)